Antibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsCladribine
Dr. Donald B. Wender, MD
NPI1861463275PAC ID2567477524
- Medicare services, 2024
- 173,988
- Medicare patients, 2024
- 1,459
- Part D claims, 2024
- 2,187
- Publications
- 5
- Clinical trials
- 10
- Practice address
- 2720 Stone Park Boulevard, Sioux City, IA 51104
- Practice phone
- Call (712) 279-3500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Wender's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Donald B. Wender is a hematologist and oncologist in Sioux City, Iowa
Dr. Wender practices at UnityPoint Health - St. Luke's in Sioux City, Iowa, part of UnityPoint Health.
Dr. Wender's NPI, 1861463275, was assigned on February 1, 2006. Dr. Wender graduated from Ohio State University College of Medicine in 1981. Dr. Wender holds Iowa license 26404.
NPI and contact details
- NPI
- 1861463275NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2567477524
- NPI enumeration date
- February 1, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (712) 279-3500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Donald B. Wender practices at UnityPoint Health - St. Luke's in Sioux City, Iowa
Dr. Wender's primary practice is UnityPoint Health - St. Luke's, at 2720 Stone Park Boulevard, Sioux City, IA 51104 in Woodbury County. The practice phone is (712) 279-3500.
- UnityPoint Health - St. Luke's2720 Stone Park Boulevard, Sioux City, IA 51104 · Woodbury CountyPhone(712) 279-3500
Source: Dmand AI Affiliation Data
Dr. Donald B. Wender is affiliated with 8 sites of care and 3 medical groups
Dr. Wender's primary practice is UnityPoint Health - St. Luke's in Sioux City, Iowa, part of UnityPoint Health. Dr. Wender is also affiliated with Floyd Valley Healthcare. The medical group on file is UnityPoint Health - St. Luke's (St. Luke's Regional Medical Center). Dmand AI also links Dr. Wender to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.
Floyd Valley HealthcareUnityPoint Health - St. Luke's (St. Luke's Regional Medical Center)3 hospitalsNames with a free account3 group practices and clinicsNames with a free account2 medical groupsNames with a free account
See all 11 affiliations for Dr. WenderSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Donald B. Wender's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wender practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UnityPoint Health - St. Luke's | Available with a free account |
| +7 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Wender practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across UnityPoint Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Donald B. Wender is one of 77 hematologists and oncologists in Iowa
Hematology and oncology is Dr. Wender's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wender is licensed in Iowa.
Specialties and state licenses
- Hematology and oncology, IowaPrimary
Hematologists and oncologists near Dr. Wender
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
77hematologists and oncologists in Iowa
8hematologists and oncologists in Sioux City
6hematologists and oncologists at UnityPoint Health - St. Luke'sSources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Donald B. Wender billed Medicare for 173,988 services in 2024
CMS data shows 173,988 Medicare services from Dr. Wender across 84 procedure codes in 2024, for 1,459 Medicare patients. Medicare paid $4,282,994 for them.
Medicare services, 2024173,988
Medicare patients1,459
Paid by Medicare$4.3M
Procedure codes84
Dr. Wender's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 117,1792024: 135,95616%
- Other services
- 2023: 1,8492024: 23,9741197%
- Lab and pathology
- 2023: 5,2622024: 5,94913%
- Tests and treatments
- 2023: 2,6962024: 2,9489%
- Office and hospital visits
- 2023: 1,9822024: 2,0483%
- Surgery
- 2023: 1,4962024: 1,64110%
- Imaging
- 2023: 202024: 1,4727260%
Where Dr. Wender's Medicare services took place, 2024
- In an office173,827100%
- In a facility1610%
Dr. Wender compared with the Iowa median for hematologists and oncologists, 2024
- Dr. Wender
- Iowa median
- Medicare services
- 173,988vs 759229.2 times
- Medicare patients
- 1,459vs 2625.6 times
- Part D claims
- 1,917vs 2547.5 times
Medians across 78 hematologists and oncologists in Iowa with Dmand AI profiles that report each measure.
Dr. Wender's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Wender?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wender and other hematologists and oncologists in Iowa.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Donald B. Wender treated 1,459 Medicare patients in 2024, average age 75
CMS counts 1,459 Medicare patients who saw Dr. Wender in 2024. The largest group is 65 to 74, with 697 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Wender's median patient age at 71, with 54% women.
Medicare patients, 20241,459
Average age75
Average risk score1.71
Also on Medicaid9%
Dr. Wender's Medicare patients by age, 2024
Dr. Wender's Medicare patients by sex, 2024
- Women76953%
- Men69047%
Chronic conditions among Dr. Wender's Medicare patients, 2024
- High blood pressure74%
- High cholesterol72%
- Cancer58%
- Arthritis38%
- Chronic kidney disease31%
- COPD29%
- Diabetes29%
- Ischemic heart disease26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Wender's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women54%
- Men46%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Donald B. Wender wrote 2,187 Medicare Part D claims in 2024
In 2024, Dr. Wender wrote 2,187 Medicare Part D claims for 411 patients. 78% of them were for generic drugs. CMS names the drug for 1,917 of them, across 43 drugs with 11 or more claims each, at $5,428,291 in total drug cost. In 2023, CMS named 1,875 claims across 46 drugs.
Part D claims, 20242,187
Drugs named by CMS43
Total drug cost$5.4M
Part D patients411
Dr. Wender's Part D claims by kind of drug, 2024
- Generic1,714 claims78%
- Brand-name and other473 claims22%
Dr. Wender's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Wender's Part D claims, 2024
- Opioids5%105 of 2,187 claims
- Antibiotics3%64 of 2,187 claims
- Antipsychotics, patients 65 and over2%52 of 2,187 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,8752024: 1,9172%
Drugs named by CMS: 43 in 2024, 46 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Donald B. Wender offers telehealth to Medicare patients
Dr. Wender accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wender as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Wender by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Donald B. Wender has 5 publications on record
Dmand AI links 5 papers to Dr. Wender, published from 2010 to 2014. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Wender's most frequent co-authors are Charles L. Loprinzi, MD, Daniel Alan Nikcevich and Robert J. Behrens, MD.
Papers5
Years published2010 to 2014
Dr. Wender's papers by year, 2010 to 2014
Topics Dr. Wender writes about most
- Antineoplastic Combined Chemotherapy Protocols
Dr. Wender's most frequent co-authors
- Charles L. Loprinzi, MD2 shared papers
- Daniel Alan Nikcevich2 shared papers
- Robert J. Behrens, MD1 shared paper
Recent publications by Dr. Wender
Antineoplastic Combined Chemotherapy ProtocolsBevacizumabCamptothecin
See who Dr. Wender researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wender works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Donald B. Wender has worked on 10 clinical trials
Dmand AI links Dr. Wender to 10 clinical trials, 7 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Wender by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Conditions in Dr. Wender's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Breast Neoplasms
- Carcinoma, Intraductal, Noninfiltrating
- Gallbladder Neoplasms
Investigators on the most trials with Dr. Wender
- Asheesh Shipstone, MD6 shared trials
- James Norman Atkins, MD5 shared trials
- Nafisa D. Burhani, MD5 shared trials
Recent clinical trials with Dr. Wender
Rectal NeoplasmsColonic NeoplasmsRegorafenibClobetasol Propionate
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO) (opens in a new tab)
RecruitingPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicCarboplatinCisplatinGemcitabine Hydrochloride
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas (opens in a new tab)
Active, not recruitingPhase 2/3
Lymphoma, Large B-Cell, DiffuseLymphoma, B-CellVenetoclaxCyclophosphamideDoxorubicin Hydrochloride
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study (opens in a new tab)
Active, not recruitingPhase 3
Lymphatic MetastasisCarcinoma, Renal CellCabozantinibIpilimumabNivolumab
Gallbladder NeoplasmsGallbladder DiseasesCisplatinGemcitabine HydrochlorideNab-paclitaxel
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Donald B. Wender received $30,153 in industry payments from 2016 to 2025
CMS Open Payments shows 1,457 general payments to Dr. Wender from 89 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,815.
General payments to Dr. Wender by program year, 2016 to 2025
General payments to Dr. Wender by kind, 2016 to 2025
$30.2Kin total
- Food and beverage$22,25174%
- Consulting fees$4,50015%
- Education$2,93110%
- Speaker and faculty fees$4652%
- Travel and lodging$60%
Companies that paid Dr. Wender the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Donald B. Wender graduated from Ohio State University College of Medicine
Dr. Wender graduated from Ohio State University College of Medicine in 1981.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Donald B. Wender's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Donald B. Wender
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Donald B. Wender's NPI number?
Dr. Donald B. Wender's NPI number is 1861463275. It was assigned on February 1, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Donald B. Wender?
Dr. Donald B. Wender is a hematologist and oncologist in Sioux City, Iowa. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Donald B. Wender practice?
Dr. Wender practices at 2720 Stone Park Boulevard, Sioux City, IA 51104. Dr. Wender's primary practice is UnityPoint Health - St. Luke's in Sioux City, Iowa, part of UnityPoint Health. Dmand AI also links Dr. Wender to 3 hospitals, 3 group practices and clinics and 2 medical groups.
What is Dr. Donald B. Wender's office phone number?
The practice phone on file for Dr. Wender is (712) 279-3500.
What is Dr. Donald B. Wender's medical license number?
Dr. Wender holds Iowa license 26404.
Which hospitals is Dr. Donald B. Wender affiliated with?
Dr. Wender practices at UnityPoint Health - St. Luke's in Sioux City, Iowa. Dr. Wender is also affiliated with Floyd Valley Healthcare. Dmand AI links Dr. Wender to 3 more hospitals.
What medical group is Dr. Donald B. Wender part of?
Dr. Wender is linked to UnityPoint Health - St. Luke's (St. Luke's Regional Medical Center). Dmand AI links Dr. Wender to 2 more medical groups.
Does Dr. Donald B. Wender accept Medicare?
Yes. CMS data shows Dr. Wender billed Medicare for 173,988 services in 2024, and Dr. Wender accepts Medicare assignment.
Does Dr. Donald B. Wender offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Wender as offering telehealth services.
How many Medicare patients does Dr. Donald B. Wender see?
CMS counts 1,459 Medicare patients who saw Dr. Wender in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. Donald B. Wender bill to Medicare?
In 2024, Dr. Wender's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J9299) and medicare temporary code (Q9967).
Where did Dr. Donald B. Wender go to medical school?
Dr. Wender graduated from Ohio State University College of Medicine in 1981.
What drugs does Dr. Donald B. Wender prescribe most?
In 2024 Medicare Part D data, Dr. Wender's most prescribed drugs by claims were Anastrozole, Letrozole and Hydroxyurea.
Has Dr. Donald B. Wender received payments from drug or device companies?
CMS Open Payments shows $30,153 in general payments to Dr. Wender from 89 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Donald B. Wender been practicing?
Dr. Wender graduated from medical school in 1981, 45 years ago.
Does Dr. Donald B. Wender do research?
Dmand AI links 5 publications to Dr. Wender, published from 2010 to 2014. Dr. Wender has worked on 10 clinical trials.
Who does Dr. Donald B. Wender publish with?
Dr. Wender's most frequent co-authors are Charles L. Loprinzi, MD (2 shared papers), Daniel Alan Nikcevich (2 shared papers) and Robert J. Behrens, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Iowa by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card